Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management.
Tirzepatide:揭開雙重靶向糖尿病和肥胖管理的新曙光。
Expert Rev Endocrinol Metab 2024-08-28
Profile of tirzepatide in the management of type 2 diabetes mellitus: design, development, and place in therapy.
Tirzepatide在2型糖尿病管理中的概況:設計、發展和治療中的地位。
Expert Opin Pharmacother 2023-03-29
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity.
「雙胰島素依賴性胰島素促分泌肽/葡萄糖樣肽-1 受體激動劑對肥胖者體重減輕的影響」。
Front Endocrinol (Lausanne) 2023-03-14
Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review.
新型雙胰高血糖素受體激動劑在代謝性疾病範疇中的應用,以 Tirzepatide 為重點:真正的改變者還是偉大的期望?一篇敘事性評論。
Biomedicines 2023-07-31
Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity.
Tirzepatide:一種新型心血管保護劑在第2型糖尿病和肥胖症中。
Curr Probl Cardiol 2024-04-02
Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence.
Tirzepatide對抗肥胖和胰島素抵抗:病理生理學方面和臨床證據。
Front Endocrinol (Lausanne) 2024-07-09
Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health.
Tirzepatide 在 2 型糖尿病管理中的創新應用及其在心血管健康中的未來前景。
Front Pharmacol 2024-09-12